Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?:: PET studies combined with microdialysis in conscious monkeys

被引:88
作者
Tsukada, H [1 ]
Nishiyama, S [1 ]
Kakiuchi, T [1 ]
Ohba, H [1 ]
Sato, K [1 ]
Harada, N [1 ]
机构
[1] Hamamatsu Photon, Cent Res Lab, Shizuoka 4348601, Japan
关键词
dopamine; dopamine D-2 receptor; C-11]raclopride; positron emission tomography; microdialysis; monkey brain;
D O I
10.1016/S0006-8993(99)01834-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of dopamine release manipulated by drugs on the in vivo binding of [C-11]raclopride in the striatum were evaluated in conscious monkeys combined with microdialysis. The in vivo binding of [C-11]raclopride was evaluated by high resolution positron emission tomography (PET), and the dopamine concentrations in the striatal extracellular fluid (ECF) were measured by microdialysis in the same animals. The systemic administration of the direct dopamine enhancers, GBR12909 (a dopamine transporter (DAT) blocker, at 0.5, 2 and 5 mg/kg) or methamphetamine (a dopamine releaser, at 0.1, 0.3 and 1 mg/kg) dose-dependently increased the dopamine concentration in the striatal ECF, and decreased in vivo [C-11]raclopride binding in the striatum. The administration of the indirect dopamine modulators benztropine (a muscarinic cholinergic antagonist, at 0.1, 0.3 and 1 mg/kg) or ketanserine (a 5-HT2 antagonist, at 0.3, 1 and 3 mg/kg) also increased dopamine level in the striatal ECF, and decreased [C-11]raclopride binding in a dose-dependent manner. However, the plots of percentage change in dopamine concentration in striatal EFC against that in [C-11]raclopride binding indicated different relationships between the effects of direct dopamine enhancers (GBR12909 and methamphetamine) and indirect dopamine modulators (benztropine and ketanserine). These results suggested that the alternation of [C-11]raclopride binding in vivo as measured by PET was differently affected by different neuronal manipulations, and not simply by the synaptic concentration of dopamine. (C) 1999 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 40 条
[1]   SEROTONIN AND DOPAMINE METABOLITES IN BRAIN-REGIONS AND CEREBROSPINAL-FLUID OF A PRIMATE SPECIES - EFFECTS OF KETAMINE AND FLUPHENAZINE [J].
BACOPOULOS, NG ;
REDMOND, DE ;
ROTH, RH .
JOURNAL OF NEUROCHEMISTRY, 1979, 32 (04) :1215-1218
[2]  
BAUMANN MH, 1994, J PHARMACOL EXP THER, V271, P1216
[3]  
BUNNEY BS, 1976, BASAL GANGLIA, P249
[4]   Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion [J].
Carson, RE ;
Breier, A ;
deBartolomeis, A ;
Saunders, RC ;
Su, TP ;
Schmall, B ;
Der, MG ;
Pickar, D ;
Eckelman, WC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (04) :437-447
[5]   EFFECTS OF CENTRAL CHOLINERGIC BLOCKADE ON STRIATAL DOPAMINE RELEASE MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN NORMAL HUMAN-SUBJECTS [J].
DEWEY, SL ;
SMITH, GS ;
LOGAN, J ;
BRODIE, JD ;
SIMKOWITZ, P ;
MACGREGOR, RR ;
FOWLER, JS ;
VOLKOW, ND ;
WOLF, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11816-11820
[6]  
DEWEY SL, 1995, J NEUROSCI, V15, P821
[7]  
DEWEY SL, 1992, J NEUROSCI, V12, P3773
[8]   AMPHETAMINE INDUCED DECREASES IN (F-18)-N-METHYLSPIROPERIDOL BINDING IN THE BABOON BRAIN USING POSITRON EMISSION TOMOGRAPHY (PET) [J].
DEWEY, SL ;
LOGAN, J ;
WOLF, AP ;
BRODIE, JD ;
ANGRIST, B ;
FOWLER, JS ;
VOLKOW, ND .
SYNAPSE, 1991, 7 (04) :324-327
[9]  
DEWEY SL, 1990, SYNAPSE, V6, P321
[10]   STRIATAL BINDING OF THE PET LIGAND C-11 RACLOPRIDE IS ALTERED BY DRUGS THAT MODIFY SYNAPTIC DOPAMINE LEVELS [J].
DEWEY, SL ;
SMITH, GS ;
LOGAN, J ;
BRODIE, JD ;
FOWLER, JS ;
WOLF, AP .
SYNAPSE, 1993, 13 (04) :350-356